Does Medicare cover Ozempic? Yes for diabetes (2026)
The most asked of the five, and the simplest answer. Ozempic is a diabetes drug, Part D covers it as one, and nothing in Medicare covers it for weight. The same molecule for weight carries the Wegovy name, and that is the one the Bridge lists.
Does Medicare cover Ozempic?
Yes if you have type 2 diabetes. Ozempic is approved to improve blood-sugar control, to reduce the risk of major cardiovascular events, and to reduce the risk of kidney disease worsening in adults with type 2 diabetes and chronic kidney disease, and Part D plans carry it as a diabetes drug. Prescribed for weight without diabetes it is excluded by statute, and the Medicare GLP-1 Bridge does not include it: the Bridge lists Foundayo, Wegovy and the Zepbound KwikPen only. With type 2 diabetes you cannot use the Bridge at all, because Part D is your route.
When Part D covers it: type 2 diabetes
All three of Ozempic's indications are for adults with type 2 diabetes, which is why a Part D plan treats it as a diabetes drug and why none of them opens a route for weight. The weight people lose on it is real, and it is off-label.
When a Part D plan refuses Ozempic to someone who has diabetes, the reason is usually the plan's own rule — a prior authorisation asking for the diagnosis, or step therapy asking for another diabetes drug first — rather than Medicare's. Those are appealable on the Part D clock below.
Prediabetes is not type 2 diabetes, so it does not qualify for Part D coverage of Ozempic. It does count for the Bridge: a BMI of 27 or more with prediabetes qualifies you there, for Wegovy.
Read from FDA prescribing information for OZEMPIC, via DailyMed and Social Security Act §1927(d)(2). Semaglutide for weight or heart risk is Wegovy, and both Medicare routes lead there. Medicare and Wegovy →
For weight alone: the GLP-1 Bridge
Ozempic is not on it. Not listed. Medicare's Bridge page names Foundayo, Wegovy and the Zepbound KwikPen and nothing else. For weight, the Bridge route to semaglutide is Wegovy — the same molecule under the weight label.
Weight loss drugs: the Medicare GLP-1 Bridge, Medicare.gov · Medicare GLP-1 Bridge, CMS, both read 10 September 2026.
What Ozempic costs on each route
| Route | What you pay |
|---|---|
| Part D, for type 2 diabetes | Your plan's tier for it; counts toward the $2,100 out-of-pocket cap for 2026 |
| GLP-1 Bridge, for weight | Not available: it is not on the Bridge list |
| Manufacturer savings card | Not usable by anyone on Medicare — federal anti-kickback rules |
| Cash, no insurance | $349 a month once titrated, read from its own published page on 2026-09-10 |
Cash price checked 2026-09-10. It does not count toward the Part D cap.
If your plan says no
72 hours for a standard coverage determination and 24 for an expedited one; for an exception the clock starts when the prescriber's supporting statement arrives. 60 days from the notice to ask the plan for a redetermination, longer if you show good cause. 42 CFR 423.568; 42 CFR 423.572; 42 CFR 423.582
- Model Coverage Determination Request Form, CMS — The form a Part D plan must accept for a coverage determination or exception request. CMS publishes it as a zip with the instructions; plans may use their own version, and yours must accept this one.
- Exceptions, CMS — What a formulary exception is, and the deadlines a plan is held to: 72 hours for a standard request, 24 for an expedited one, counted from when the prescriber's supporting statement arrives rather than from your call.
- Model Redetermination Request Form, CMS — The first-level appeal after a denial, effective 1 January 2025. You have 60 days from the denial notice.
At a denial, the appeal letter builder fills in the indication and the criterion; it runs in your browser and sends nothing.
The law this page rests on
The exclusion is a statute, the Bridge is a CMS demonstration, and the cap is set each year by CMS.
- Social Security Act §1927(d)(2), Office of the Law Revision Counsel — The statute itself, listing “agents when used for anorexia, weight loss, or weight gain” among the drugs a programme may exclude.
- Manufacturer safeguards may not prevent copayment coupon use for Part D drugs, HHS Office of Inspector General — Why a manufacturer copay card cannot be used with a federal programme, from the office that enforces it.
- Weight-loss drugs, Medicare.gov — Medicare's own page on what it does and does not cover for weight loss.
Medicare and Ozempic, answered
- Does Medicare cover Ozempic for weight loss?
- No. Part D excludes drugs used for weight loss, and the Medicare GLP-1 Bridge — the one route around that — does not list Ozempic. It lists Wegovy, the same molecule approved for weight.
- Will Medicare cover Ozempic if I have prediabetes?
- Not Ozempic: its indications all require type 2 diabetes. Prediabetes with a BMI of 27 or more does qualify you for the GLP-1 Bridge, where the semaglutide on offer is Wegovy at $50 a month.
- Is Ozempic covered by Medicare Advantage?
- The same way as by a standalone Part D plan, because an Advantage plan's drug benefit is Part D: covered for type 2 diabetes on the plan's formulary, excluded for weight. Extra Advantage benefits cannot add back a use the statute removes.